↓ Skip to main content

Dove Medical Press

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, November 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
17 Mendeley